about
Estimating the potential survival gains by eliminating socioeconomic and sex inequalities in stage at diagnosis of melanoma.The impact of eliminating age inequalities in stage at diagnosis on breast cancer survival for older womenComparison of different approaches to estimating age standardized net survival.A comprehensive assessment of the impact of errors in the cancer registration process on 1- and 5-year relative survival estimates.Regional variations in German mesothelioma mortality rates: 2000–2010.How much of the deprivation gap in cancer survival can be explained by variation in stage at diagnosis: an example from breast cancer in the East of England.Determinants of excess mortality following unprotected left main stem percutaneous coronary intervention.Estimating the impact of a cancer diagnosis on life expectancy by socio-economic group for a range of cancer types in England.International trends in lung cancer incidence by histological subtype: adenocarcinoma stabilizing in men but still increasing in women.Estimating net survival in population-based cancer studies.Sex Differences in Treatments, Relative Survival, and Excess Mortality Following Acute Myocardial Infarction: National Cohort Study Using the SWEDEHEART Registry.Direct likelihood inference on the cause-specific cumulative incidence function: A flexible parametric regression modelling approach.Assessment of lead-time bias in estimates of relative survival for breast cancer.Projecting cancer incidence using age-period-cohort models incorporating restricted cubic splines.Comparison of methods for calculating relative survival in population-based studies.Understanding the impact of socioeconomic differences in breast cancer survival in England and Wales: Avoidable deaths and potential gain in expectation of lifeCare needed in interpretation of cancer survival measuresPersonalized Detection of Circulating Tumor DNA Antedates Breast Cancer Metastatic Recurrence
P50
Q35275296-DCF0A1AD-91FB-44BC-9366-12AFABFE145BQ35275317-8920DC09-508A-462A-9CF7-DE0C1EDBDBCFQ35746703-4C5E02D2-1166-45AA-86F1-A29FF6A83FC4Q36671912-9046A64D-1AAE-4A92-A77A-FE7277E5008EQ38421559-053114F7-8A23-47AE-95E7-EC051EA64BBCQ38426731-070D7138-ADFE-4DFD-87E3-4389A5604970Q38884187-4195B812-E8CF-42EF-B3FF-80036B6DF5BAQ40045660-03FF2CDF-DAF8-4DED-8809-E12E07EF7B80Q42228519-0C9D933F-69D4-4FBA-B674-93D17BC361FDQ44465402-E9548769-2B47-41CB-9E87-A926C0A9890BQ47307566-92248568-98CB-4848-92A7-5DBFB1A96A92Q47877490-7948D974-C398-437C-A9BD-00ADB80D56B1Q50986912-C4102985-A811-46F6-AD77-E494141CD067Q51539656-877C4FBD-3B50-4872-BB31-6D483668C26BQ53087901-16928580-CD18-4BE1-8CE7-CE4F96C8BD09Q59825759-AEC31852-44B8-4EB1-8AC1-BEF4D941A571Q61875134-5D80E001-6D1E-4DC1-96E7-DACDFE87C339Q93137216-F1B0A0FD-1690-4872-97F7-707DF6FA97E3
P50
description
researcher ORCID ID = 0000-0003-1557-6697
@en
wetenschapper
@nl
name
Mark J Rutherford
@ast
Mark J Rutherford
@en
Mark J Rutherford
@es
Mark J Rutherford
@nl
type
label
Mark J Rutherford
@ast
Mark J Rutherford
@en
Mark J Rutherford
@es
Mark J Rutherford
@nl
prefLabel
Mark J Rutherford
@ast
Mark J Rutherford
@en
Mark J Rutherford
@es
Mark J Rutherford
@nl
P1153
36816409300
P21
P31
P496
0000-0003-1557-6697